688336.SH
三生国健
SSE · Healthcare · Biotechnology · CN
CNY 43.45
−8.81%Forward multiples
Based on analyst estimates
- P/E forward
- 101.89x
- P/E 2026E
- 59.95x
- P/E 2027E
- 47.14x
- P/E 2028E
- 40.63x
- P/S forward
- 18.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.43x
- PEG TTM
- 0.03x
- Price / book
- 4.58x
- Price / sales
- 8.75x
- Price / cash flow
- 13.54x
Enterprise value
- Enterprise value
- —
- EV / sales
- —
- EV / EBITDA
- —
- EV / EBIT
- —
- Market cap
- CNY 38.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026